Page 9 - Erik Manting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mendus to participate in upcoming conferences in June 2023

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation.

United statesCorey davisMario brkuljErik mantingValency communicationsInternational conventionLifesci advisorsSci advisorsNasdaq stockholmStockholm stock exchange immuMendus ab

Mendus AB: Report from the Annual General Meeting of Mendus AB (publ) on 12 May 2023

At the annual general meeting of Mendus AB , reg. no. 556629-1786, on 12 May 2023 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the. | May 12, 2023

Corey davisCharlotte holmstrandAndrea van elsasSven andreassonHans preustingErik mantingChristine lindDharminder chahalMario brkuljValency communicationsLifesci advisorsNasdaq stockholmSci advisorsMendus ab publ stock exchangePress releaseF immu se0005003654

Mendus announces two upcoming presentations at the EHA2023 Hybrid Congress

MENDUS TO PRESENT UPDATES ON IMMUNOMONITORING DATA FROM ADVANCE II TRIAL AND PROGRESS ON THE DEVELOPMENT OF ITS NK CELL THERAPY PROGRAM Mendus AB , a biopharmaceutical company focused on. | May 11, 2023

Erik mantingCorey davisMario brkuljLifesci advisorsEuropean hematology associationValency communicationsNasdaq stockholmSci advisorsMendus ab publ stock exchangePress releaseOcused immu se0005003654

Mendus announces positive data from the ALISON trial in ovarian cancer presented at the AACR Annual Meeting 2023

VIDIDENCEL INDUCES DURABLE VACCINE-INDUCED T-CELL RESPONSES IN THE MAJORITY OF PATIENTS Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today. | April 19, 2023

United statesCorey davisErik mantingMario brkuljAmerican association for cancer researchUniversity medical center groningenLifesci advisorsValency communicationsDepartment of obstetricsAmerican associationCancer researchAnnual meetingImmunomodulatory agentsInterventions sessionHigh grade serous ovarian cancerNasdaq stockholm

Mendus AB: Mendus (publ) publishes the Annual Report for 2022 and holds investor call on April 17th

Mendus AB: Mendus (publ) publishes the Annual Report for 2022 and holds investor call on April 17th
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Corey davisErik mantingMario brkuljLifesci advisorsValency communicationsAnnual reportSecurities marketsSci advisorsNasdaq stockholm